Evidence map›Paper›PMID 39897040›Full record

ReviewInternational journal of biological sciences2025

Traditional Chinese Medicine for Viral Pneumonia Therapy: Pharmacological Basis and Mechanistic Insights.

Yinglu Bai, Tengwen Liu, Shuwen Zhang, Yifan Shi, Yumei Yang, Maoyu Ding, Xiaowei Yang, Shanshan Guo, Xiaolong Xu, Qingquan Liu

Abstract readReview
In one paragraph

Review in International journal of biological sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Frontiers in pharmacology · 2025
    Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
  7. Pharmaceuticals (Basel, Switzerland) · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yinglu BaiBeijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing 100010, China.
Tengwen LiuChengdu University of Traditional Chinese Medicine, Chengdu, 611137, China.
Shuwen ZhangBeijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing 100010, China.
Yifan ShiBeijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing 100010, China.
Yumei YangBeijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing 100010, China.
Maoyu DingBeijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing 100010, China.
Xiaowei YangInstitute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, 100700, China.
Shanshan GuoInstitute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, 100700, China.
Xiaolong XuBeijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing 100010, China.
Qingquan LiuBeijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing 100010, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Different respiratory viruses might cause similar symptoms, ranging from mild upper respiratory tract involvement to severe respiratory distress, which can rapidly progress to septic shock, coagulation disorders, and multiorgan failure, ultimately leading to death. The COVID-19 pandemic has shown that predicting clinical outcomes can be challenging because of the complex interactions between the virus and the host. Traditional Chinese medicine (TCM) has distinct benefits in the treatment of respiratory viral illnesses due to its adherence to the principles of "different treatments for the same disease" and "same treatment for different diseases". This paper examines the effectiveness and underlying mechanisms of key TCM treatments for viral pneumonia in recent years. The aim of this study was to discover and confirm the active substances of TCM with potential therapeutic effects on viral pneumonia and their integrative effects and synergistic mechanisms and to provide a scientific basis for elucidating the effectiveness of TCM treatment and drug discovery. Furthermore, a thorough analysis of previous research is necessary to evaluate the effectiveness of TCM in treating viral pneumonia.

Indexed as

COVID-19 Drug TreatmentDrugs, Chinese HerbalMedicine, Chinese TraditionalPneumonia, ViralAntiviral AgentsCOVID-19HumansSARS-CoV-2Antiviral AgentsDrugs, Chinese Herbaladenovirusinfluenza virusrespiratory syncytial virussevere acute respiratory syndrome-coronavirus 2traditional Chinese medicineviral pneumonia

Identifiers

PMID39897040
PMCPMC11781171

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.